Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...
Artificial intelligence has taken many forms over the years and is still evolving. Will machines soon surpass human knowledge ...
Baron Durable Advantage Fund had a strong second quarter of 2025, outperforming its benchmark, the S&P 500 Index. Read more ...
Phosphoproteomic profiling of Osimertinib drug-tolerant persister (DTP) cells identified dynamic signaling transitions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback